Search Results

There are 13232 results for: content related to: Rituximab or a second anti–tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti–tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register

  1. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  2. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  3. You have free access to this content
    Research Poster Abstracts

    Value in Health

    Volume 11, Issue 6, November 2008, Pages: A362–A659,

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1524-4733.2008.00453_2.x

  4. You have free access to this content
    Research Podium Abstracts

    Value in Health

    Volume 11, Issue 6, November 2008, Pages: A335–A362,

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1524-4733.2008.00453_1.x

  5. You have free access to this content
    Canadian Estimates of Health Care Utilization Costs for Rheumatoid Arthritis Patients With and Without Therapy With Biologic Agents

    Arthritis Care & Research

    Volume 66, Issue 9, September 2014, Pages: 1319–1327, Arto E. Ohinmaa, Nguyen X. Thanh, Cheryl Barnabe, Liam Martin, Anthony S. Russell, Susan G. Barr and Walter P. Maksymowych

    Version of Record online : 26 AUG 2014, DOI: 10.1002/acr.22293

  6. Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue S1, August 2011, Pages: S1–S364,

    Version of Record online : 12 AUG 2011, DOI: 10.1002/pds.2206

  7. You have free access to this content
    Contributed Podium Presentations

    Value in Health

    Volume 9, Issue 3, May 2006, Pages: A1–A23,

    Version of Record online : 2 MAY 2006, DOI: 10.1111/j.1524-4733.2006.00102_1.x

  8. You have free access to this content
    Contributed Poster Presentations

    Value in Health

    Volume 10, Issue 6, November/December 2007, Pages: A243–A475,

    Version of Record online : 24 OCT 2007, DOI: 10.1111/j.1524-4733.2007.00263_2.x

  9. You have free access to this content
    Contributed Podium Presentations

    Value in Health

    Volume 10, Issue 6, November/December 2007, Pages: A221–A242,

    Version of Record online : 24 OCT 2007, DOI: 10.1111/j.1524-4733.2007.00263_1.x

  10. You have free access to this content
    Contributed Poster Presentations

    Value in Health

    Volume 9, Issue 3, May 2006, Pages: A24–A173,

    Version of Record online : 2 MAY 2006, DOI: 10.1111/j.1524-4733.2006.00102_2.x

    Corrected by:

    ERRATUM

    Vol. 9, Issue 6, A410, Version of Record online: 14 SEP 2006

  11. You have free access to this content
    Research Podium Abstracts

    Value in Health

    Volume 12, Issue 3, May 2009, Pages: A1–A19,

    Version of Record online : 15 APR 2009, DOI: 10.1111/j.1524-4733.2009.00537_1.x

  12. You have free access to this content
    Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

    Arthritis & Rheumatism

    Volume 56, Issue 1, January 2007, Pages: 13–20, Kimme L. Hyrich, Mark Lunt, Kath D. Watson, Deborah P. M. Symmons, Alan J. Silman and British Society for Rheumatology Biologics Register

    Version of Record online : 28 DEC 2006, DOI: 10.1002/art.22331

  13. You have free access to this content
    Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry

    Arthritis & Rheumatism

    Volume 65, Issue 5, May 2013, Pages: 1213–1223, Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, Martin Dehn Andersen, Ulrik Tarp, Anne Gitte Loft, Hanne M. Lindegaard, Mette Holland-Fischer, Henrik Nordin, Dorte Vendelbo Jensen, Christian Holkmann Olsen and Merete Lund Hetland

    Version of Record online : 23 APR 2013, DOI: 10.1002/art.37876

  14. You have free access to this content
    ABSTRACTS – Online Panel Discussion (i-Pos)

    International Journal of Rheumatic Diseases

    Volume 11, Issue s1, September 2008, Pages: A84–A514,

    Version of Record online : 31 AUG 2008, DOI: 10.1111/j.1479-8077.2008.00373.x

  15. You have full text access to this OnlineOpen article
    Comparative efficacy of switching to natalizumab in active multiple sclerosis

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 4, April 2015, Pages: 373–387, Timothy Spelman, Tomas Kalincik, Annie Zhang, Fabio Pellegrini, Heinz Wiendl, Ludwig Kappos, Larisa Tsvetkova, Shibeshih Belachew, Robert Hyde, Freek Verheul, Francois Grand-Maison, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Alessandra Lugaresi, Jeannette Lechner-Scott, Celia Oreja-Guevara, Raymond Hupperts, Thor Petersen, Michael Barnett, Maria Trojano, Helmut Butzkueven and on behalf of the MSBase Investigators and the TOP investigators

    Version of Record online : 27 FEB 2015, DOI: 10.1002/acn3.180

  16. Biologics-Based Therapy for the Treatment of Rheumatoid Arthritis

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 30–43, D L Scott

    Version of Record online : 14 DEC 2011, DOI: 10.1038/clpt.2011.278

  17. You have free access to this content
    Research Poster Abstracts

    Value in Health

    Volume 12, Issue 3, May 2009, Pages: A19–A203,

    Version of Record online : 15 APR 2009, DOI: 10.1111/j.1524-4733.2009.00537_2.x

  18. Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

    Arthritis & Rheumatology

    Volume 67, Issue 9, September 2015, Pages: 2303–2310, Katie L. Druce, Gareth T. Jones, Gary J. Macfarlane and Neil Basu

    Version of Record online : 26 AUG 2015, DOI: 10.1002/art.39238

  19. You have free access to this content
    Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: Experience from a large US cohort

    Arthritis Care & Research

    Volume 63, Issue 12, December 2011, Pages: 1672–1679, Jie Zhang, Ying Shan, George Reed, Joel Kremer, Jeffrey D. Greenberg, Scott Baumgartner and Jeffrey R. Curtis

    Version of Record online : 29 NOV 2011, DOI: 10.1002/acr.20643

  20. The Magnitude and Nature of Risk Selection in Employer-Sponsored Health Plans

    Health Services Research

    Volume 39, Issue 6p1, December 2004, Pages: 1817–1838, Sean Nicholson, Kate Bundorf, Rebecca M. Stein and Daniel Polsky

    Version of Record online : 8 NOV 2004, DOI: 10.1111/j.1475-6773.2004.00320.x